PharmAthene Submits Proposal To BARDA In Response To Broad Agency Announcement For Advanced Research And Development For Valortim(R)

PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced that it has submitted a proposal to the Biomedical Advanced Research and Development Authority (BARDA) in response to a Broad Agency Announcement (BAA-BARDA-09-34) for advanced research and development of medical countermeasures for chemical, biological, radiological and nuclear threats.

More: continued here

Filed under: Bio-terrorism on June 4th, 2009